1-3 of 3
Ekin Kircali, MD
Close
Sort by
Journal Articles

Comparison of Two Alkylating Agents Among Refractory Multiple Myeloma: Published and Our Retrospective Bendamustine Combination Experience with Melflufen As Single Agent

Ekin Kircali, MD, Guldane Cengiz, MD, Sevgi Çolak, MD, Mehmet Gunduz, MD, Pinar Ataca Atilla, MD, Erden Atilla, MD, Mehmet Özen, MD, Muhit Ozcan, Meral Beksac, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 13–14.
https://doi.org/10.1182/blood-2020-137486
Published: 2020
Journal Articles

Hepatitis B (HBV) Reactivation Rate and Fate Among Multiple Myeloma Patients Receiving Lenalidomide Containing Regimens: A Single Center Experience

Pinar Ataca, MD, Erden Atilla, MD, Ekin Kircali, MD, Ramazan Idilman, MD, Meral Beksac, MD
Journal: Blood
Blood (2015) 126 (23): 5377.
https://doi.org/10.1182/blood.V126.23.5377.5377
Published: 2015
Journal Articles

Is R-CODOX-M/IVAC Inferior to Other Regimens in Burkitt’s Lymphoma: A Single Center Experience

Erden Atilla, MD, Ugur Sahin, MD, Pinar Ataca, MD, Atilla Uslu, MD, Ekin Kircali, MD, Berna Atesagaoglu, MD, Gultekin Pekcan, MD, Mustafa Merter, MD, Mehmet Gunduz, MD, Mehmet Ozen, MD, Sinem Civriz Bozdag, MD, Selami Kocak Toprak, MD, Pervin Topcuoglu, MD, Onder Arslan, MD, Taner Demirer, MD, Hamdi Akan, MD, Gunhan Gurman, MD, Meral Beksac, MD, Osman Ilhan, MD, Nahide Konuk, MD, Muhit Ozcan, MD
Journal: Blood
Blood (2014) 124 (21): 5448.
https://doi.org/10.1182/blood.V124.21.5448.5448
Published: 2014